Search
KraneShares Man Buyout Beta Index ETF
BUYOAdd to Watchlist
32.504USD
+0.187+0.58%
Close 11-06 16:00（ET）
200.00Volume
6.49KTurnover
Today
+0.58%
5 Days
-1.59%
1 Month
+0.10%
6 Months
+4.55%
Year to Date
+16.87%
1 Year
+20.92%
Key Figures
32.355Open
32.317Prev. Close
32.504High
32.320Low
200.00Volume
6.49KTurnover
0.24Volume Ratio
34.52552wk High
25.71452wk Low
1.54KAvg Volume
0.01%Div Yield
0.002Est. Annual Div.
Extended MarketInvestment Segment
NoInverse ETF
NoLeveraged ETF
--Leverage Factor
32.590NAV
USDNAV Currency
3.32P/B
19.38Price to earnings ratio
KraneShares Man Buyout Beta Index ETF Profile
Ticker SymbolBUYO
Asset ClassEquity
Fund ManagerKraneShares
DomicileUS
Expense Ratio0.89%
Founded at2024-10-08
Websitehttps://kraneshares.com/buyo
Tracking IndexMan Buyout Beta Index - Benchmark TR Gross
BUYO was created on 2024-10-08 by KraneShares. The fund's investment portfolio concentrates primarily on extended market equity. The ETF currently has 16.34m in AUM and 323 holdings. BUYO tracks a market-cap-weighted index designed to deliver private-equity-like performance through investments in small- and mid-cap US stocks. Stock selection is based on fundamental analysis.
Top 10 Holdings
No.Name
Price
Change
Chg %
Shares Held
Weight
Market Value
Watchlist
News Corp Class A
NWSA
26.385
-0.095
-0.36%
9.06K
1.72%
$281.62K
Asana Inc Ordinary Shares - Class A
ASAN
10.610
-0.560
-5.01%
20.46K
1.44%
$235.28K
Encompass Health Corp
EHC
137.540
-3.730
-2.64%
1.84K
1.41%
$231.48K
4
Affiliated Managers Group Inc
AMG
362.960
+12.420
+3.54%
490.00
1.18%
$193.81K
5
Morningstar Inc
MORN
244.150
-3.020
-1.22%
797.00
1.09%
$177.99K
6
Frontdoor Inc
FTDR
97.090
+1.110
+1.16%
1.94K
1.02%
$166.73K
7
Match Group Inc Ordinary Shares - New
MTCH
39.030
-0.130
-0.33%
3.55K
1.00%
$163.02K
8
Teladoc Health Inc
TDOC
8.770
-0.640
-6.80%
25.63K
0.99%
$161.99K
9
Materion Corp
MTRN
186.110
+8.640
+4.87%
725.00
0.97%
$158.86K
10
LifeStance Health Group Inc Ordinary Shares
LFST
13.770
+0.340
+2.53%
12.37K
0.95%
$155.39K
KraneShares Man Buyout Beta Index ETF Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Strong sell
KraneShares Man Buyout Beta Index ETF News
More news coming soon, stay tuned...
Popular Instruments
51290.600
-208.500 (-0.41%)
26964.500
+329.300 (+1.24%)
7380.000
+23.100 (+0.31%)
12797.000
-1.000 (-0.01%)
58142.000
+876.000 (+1.53%)
6140.600
-37.200 (-0.60%)
89.857
-0.176 (-0.20%)
342.370
-1.800 (-0.52%)
186.640
+5.040 (+2.78%)
4065.670
-33.020 (-0.81%)
FAQs
What is the current price of KraneShares Man Buyout Beta Index ETF (BUYO)?
The current price of KraneShares Man Buyout Beta Index ETF (BUYO) is 32.50. Market data may be delayed; please refer to the timestamp displayed on the page.
What is the 52-week high of KraneShares Man Buyout Beta Index ETF?
The 52-week high of KraneShares Man Buyout Beta Index ETF is 34.52. Please refer to the page timestamp for the latest data.
What is the 52-week low of KraneShares Man Buyout Beta Index ETF?
The 52-week low of KraneShares Man Buyout Beta Index ETF is 25.71. Please refer to the page timestamp for the latest data.
What is the NAV of KraneShares Man Buyout Beta Index ETF?
The NAV of KraneShares Man Buyout Beta Index ETF is 32.59 today. NAV represents the fund’s total assets minus its liabilities and helps indicate its underlying per-share value.
How is KraneShares Man Buyout Beta Index ETF (BUYO) performing?
The trading turnover of KraneShares Man Buyout Beta Index ETF (BUYO) is 6.49K. Its price changed by -0.20% over the past month, while its one-year return is 18.95%. View the KraneShares Man Buyout Beta Index ETF price chart for more details.
Is KraneShares Man Buyout Beta Index ETF (BUYO) a safe investment?
No investment is completely risk-free. The risk level of KraneShares Man Buyout Beta Index ETF (BUYO) depends on its underlying assets, strategy, liquidity, fees, and market conditions. Diversification may reduce potential losses but cannot eliminate them, and past performance does not guarantee future results. Before investing, consider whether the fund aligns with your goals and risk tolerance. This is not investment advice.